medigraphic.com
ISSN 1561-2996 (Electronic)
ISSN 0864-0289 (Print)

2016, Number 2

<< Back Next >>

Rev Cubana Hematol Inmunol Hemoter 2016; 32 (2)

NPM1-A mutation in cuban patients with acute myeloid leukemia, its coexistence with other molecular disorders

Amor-Vigil AM, Díaz-Alonso CA, Garrote-Santana H

Language: Spanish
References: 13
Page: 249-254
PDF size: 94.13 Kb.


ABSTRACT

In 2005 the frequent detection of nucleophosmin-1 (NPM1) gene mutation in acute myeloid leukemia (AML) was reported for the first time. At present, this represents the most frequent gene alteration in AML which has demonstrated prognostic significance. The most common NPM1 mutation type appearing in 75 - 80 % of the patients, is the NPM1-A. Through an allele-specific RT-PCR assay the NPM1-A was studied in 32 AML Cuban patients at the onset of the disease. RNA samples conserved a -20°C were used. Eleven patients (34,4%) showed NPM1-A. Among the NPM1-A positives patients, one presented two additional molecular disorders: the AML1-ETO fusion gen and the FLT3 internal tandem duplication (FLT3-ITD). In other patient, NPM1-A was concomitant to FLT3-ITD and in a third one, the AML1-ETO fusion gen was found besides NPM1-A. An extended study will allow to correlate NPM1-A mutation and outcome disease, and will let us know the interaction with other molecular markers.


REFERENCES

  1. Arber DA, Brunning RD, Le Beau MM, Falini B, Vardiman JW, Porwit A, et al. Acute myeloid leukaemia with recurrent genetic abnormalities. En: Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, et al (eds). WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues, 4th ed. Lyon, France: International Agency for Research on Cancer: 2008.

  2. Falini B, Martelli MP, Bolli N, Sportoletti P, Liso A, Tiacci E, et al. Acute myeloid leukemia with mutated nucleophosmin (NPM1): is it a distinct entity? Blood. 2011 Jan;117(4):1109-20. doi:10.1182/blood-2010-08-299990

  3. Federici L, Falini B. Nucleophosmin mutations in acute myeloid leukemia: A tale of protein unfolding and mislocalization. Protein Science. 2013 Feb;22(5):545-56. doi:10.1002/pro.2240

  4. Pastore F, Greif PA, Schneider S, Ksienzyk B, Mellert G, Zellmeier E, et al. The NPM1 Mutation Type Has No Impact on Survival in Cytogenetically Normal AML. PLoS ONE. 2014;9(10):e109759. doi:10.1371/journal.pone.0109759.

  5. Shamaa S, Laimon N, Aladle DA, Azmy E, Elghannam DM, Salem DA, et al. Prognostic implications of NPM1 mutations and FLT3 internal tandem duplications in Egyptian patients with cytogenetically normal acute myeloid leukemia. Hematology. 2014 Jan;19(1):22-30. doi:10.1179/1607845413Y.0000000085.

  6. Falini B, Martelli MP, Pileri SA, Mecucci C. Molecular and alternative methods for diagnosis of acute myeloid leukemia with mutated NPM1: flexibility may help. Haematologica. 2010 Apr;95(4):529-34. doi:10.3324/haematol.2009.0178225.

  7. Ottone T, Ammatuna E, Lavorgna S, Noguera NI, Buccisano F, Vendittiet A, et al. An allele-specific RT-PCR assay to detect type A mutation of the nucleophosmin-1 gene in acute myeloid leukemia. J Mol Diagnostics. 2008 May;10(3):212-6. doi:10.2353/jmoldx.2008.070166.

  8. van Dongen JJ, Macintyre EA, Gabert JA, Delabesse E, Rossi V, Saglio G, et al. Standardized RT-PCR analysis of fusion gene transcripts from chromosome aberrations in acute leukemia for detection of minimal residual disease. Report of the BIOMED-1 Concerted Action: investigation of minimal residual disease in acute leukemia. Leukemia. 1999;13:1901-28. doi:10.1038/sj/leu/2401245.

  9. Braoudaki M, Papathanassiou C, Katsibardi K, Tourkadoni N, Karamolegou K and Tzortzatou-Stathopoulou F. The frequency of NPM1 mutations in childhood acute myeloid leukemia. J Hematol Oncol. 2010 Oct;3(1):41-5. doi:10.1186/1756-8722-3-41

  10. Schneider F, Hoster E, Schneider S, Dufour A, Benthaus T, Kakadia PM, et al. Age-dependent frequencies of NPM1 mutations and FLT3-ITD in patients with normal karyotype AML (NK-AML). Ann Hematol. 2012;91:9-18.

  11. Falini B, Mecucci C, Saglio G, Lo Coco F, Diverio D, Brown P, et al. NPM1 mutations and cytoplasmic nucleophosmin are mutually exclusive of recurrent genetic abnormalities: a comparative analysis of 2562 patients with acute myeloid leukemia. Haematologica. 2008 Mar;93(3):439-42. doi: 10.3324/haematol.12153.

  12. Balatzenko G, Spassov B, Stoyanov N, Ganeva P, Dikov T, Konstantinov S, et al. NPM1 Gene Type A Mutation in Bulgarian Adults with Acute Myeloid Leukemia: A Single-Institution Study. Turk J Hematol. 2014 Mar;31(1):40-8. doi: 10.4274/Tjh.2013.0023.

  13. Falini B, Mecucci C, Tiacci E, Alcalay M, Rosati R, Pasqualucci L, et al. Cytoplasmic nucleophosmin in acute myelogenous leukemia with a normal karyotype. N Engl J Med. 2005 Jan;352(3):254-66.




2020     |     www.medigraphic.com